Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis: 5-Year Results from a 52-Week Randomized Controlled Trial and Open-Label Extension Study

被引：0
|
作者：
Keystone, Edward [1 ]
Landewe, Robert
van Vollenhoven, Ronald [2 ]
Combe, Bernard [3 ]
Strand, Vibeke [4 ]
Mease, Phillip [5 ,6 ]
Shaughnessy, Laura
VanLunen, Brenda
van der Heijde, Desiree [7 ]
机构：
[1] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[2] Karolinska Inst, Stockholm, Sweden
[3] Hop Lapeyronie, F-34295 Montpellier, France
[4] Stanford Univ, Portola Valley, VA USA
[5] Swedish Med Ctr, Seattle, WA USA
[6] Univ Washington, Sch Med, Seattle, WA USA
[7] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
JOURNAL OF RHEUMATOLOGY | 2014年 / 41卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
24
引用
收藏
页码：1455 / 1456
页数：2
相关论文
共 50 条
  • [41] Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial
    Grossman, J
    Smith, LJ
    Wilson, AM
    Thyrum, PT
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (04) : 361 - 369
  • [42] Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
    Ruperto, Nicolino
    Lovell, Daniel J.
    Cuttica, Ruben
    Woo, Patricia
    Meiorin, Silvia
    Wouters, Carine
    Silverman, Earl D.
    Balogh, Zsolt
    Henrickson, Michael
    Davidson, Joyce
    Foeldvari, Ivan
    Imundo, Lisa
    Simonini, Gabriele
    Oppermann, Joachim
    Xu, Stephen
    Shen, Yaung-Kaung
    Visvanathan, Sudha
    Fasanmade, Adedigbo
    Mendelsohn, Alan
    Martini, Alberto
    Giannini, Edward H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (04) : 718 - 722
  • [43] Long-term efficacy & safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis: Findings from an open-label treatment extension.
    Lovell, D. J.
    Ruperto, N.
    Cuttica, R.
    Woo, P.
    Espada, G.
    Wouters, C.
    Silverman, E. D.
    Balogh, Z.
    Henrickson, M.
    Davidson, J.
    Foeldvari, I.
    Imundo, L.
    Simonini, G.
    Oppermann, J.
    Shen, Y. K.
    Visvanathan, S.
    Fasanmade, A.
    Mendelsohn, A.
    Giannini, E. H.
    Martini, A.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S632 - S632
  • [44] Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study
    Jürgen Wollenhaupt
    Eun-Bong Lee
    Jeffrey R. Curtis
    Joel Silverfield
    Ketti Terry
    Koshika Soma
    Chris Mojcik
    Ryan DeMasi
    Sander Strengholt
    Kenneth Kwok
    Irina Lazariciu
    Lisy Wang
    Stanley Cohen
    [J]. Arthritis Research & Therapy, 21
  • [45] Long-Term Safety of Filgotinib in Patients with Psoriatic Arthritis, Week 52 Safety Data from a Phase 2 Open-Label Extension Study
    Gladman, Dafna
    Coates, Laura
    Mease, Philip
    van den Bosch, Filip
    Rychlewska-Hanczewska, Anna
    Tasset, Chantal
    Meuleners, Luc
    Trivedi, Mona
    Guo, Ying
    Besuyen, Robin
    Helliwell, Philip
    [J]. JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1066 - 1067
  • [46] Long-term Safety of Filgotinib in Patients with Psoriatic Arthritis, Week 52 Safety Data from a Phase 2 Open-Label Extension Study
    Coates, Laura
    Mease, Philip
    Gladman, Dafna
    Van den Bosch, Filip
    Rychlewska-Hanczewska, Anna
    Tasset, Chantal
    Meuleners, Luc
    Trivedi, Mona
    Gao, Jingjing
    Besuyen, Robin
    Helliwell, Philip
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [47] Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study
    Iwata, Nakao
    Ishigooka, Jun
    Naoi, Ichiro
    Matsumoto, Masahiro
    Kanamori, Yuichi
    Nakamura, Hiroshi
    Higuchi, Teruhiko
    [J]. CNS DRUGS, 2020, 34 (01) : 103 - 116
  • [48] LONG-TERM SAFETY AND EFFICACY OF BLONANSERIN ORAL TABLET (DSP-5423) IN ADOLESCENTS WITH SCHIZOPHRENIA: A 52-WEEK, MULTICENTER, OPEN-LABEL, EXTENSION STUDY
    Saito, Takuya
    Nakamura, Hiroshi
    Ishigooka, Jun
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 60 (10): : S216 - S216
  • [49] Sustained Efficacy and Long-term Safety of Erenumab in Patients with Episodic Migraine: 4+Year Results of a 5-Year, Open-Label Extension Study
    Ashina, M.
    Goadsby, P. J.
    Reuter, U.
    Silberstein, S. D.
    Dodick, D. W.
    Chou, D. E.
    Klatt, J.
    Xue, F.
    Zhang, F.
    Cheng, S.
    Mikol, D. D.
    [J]. HEADACHE, 2019, 59 : 25 - 25
  • [50] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
    Cohen, Stanley
    Pablos, Jose L.
    Pavelka, Karel
    Mueller, Gerard Anton
    Matsumoto, Alan
    Kivitz, Alan
    Wang, Hui
    Krishnan, Eswar
    [J]. ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
12345